Penetrium Bioscience Inc. (KOSDAQ:187660)
South Korea · Delayed Price · Currency is KRW 8,270.00
-430.00 (-4.94%)
At close: May 15, 2026
Penetrium Bioscience Market Cap
Penetrium Bioscience has a market cap or net worth of 476.44 billion as of May 15, 2026. Its market cap has increased by 550.90% in one year.
Market Cap
476.44B
Enterprise Value
479.69B
Revenue
9.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,270.00
Market Cap Chart
Since June 3, 2021, Penetrium Bioscience's market cap has increased from 215.74B to 476.44B, an increase of 120.84%. That is a compound annual growth rate of 17.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 476.44B | 265.55% |
| Dec 30, 2025 | 130.34B | 86.73% |
| Dec 30, 2024 | 69.80B | 57.99% |
| Dec 28, 2023 | 44.18B | 1.39% |
| Dec 29, 2022 | 43.58B | -66.41% |
| Dec 30, 2021 | 129.71B | -39.88% |
| Jun 3, 2021 | 215.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DreamCIS | 182.54B |
| HLB bioStep | 107.65B |
| P&K Skin Research Center | 67.44B |
| WOOJUNG BIO | 49.82B |
| C&R Research | 39.42B |
| DT&CRO CO. | 37.07B |
| SLS BIO | 26.89B |
| BioInfra | 19.43B |